文献速递胃肠外科

单孔与多孔腹腔镜结肠癌根治术随机对照试验的长期结局

Long-term Outcomes of a Randomized Controlled Trial of Single-incision Versus Multi-port Laparoscopic Colectomy for Colon Cancer.
PubMed 文献 · Ann Surg · 2021-01-01

该随机对照试验纳入200例临床分期0-III期结肠癌患者,比较单孔腹腔镜结肠切除术(SILC)与多孔腹腔镜结肠切除术(MPC)的5年无复发生存(RFS)、总生存(OS)及复发模式。结果显示两组5年RFS、OS及复发模式均无统计学显著差异,SILC可能是有选择结肠癌患者可接受的治疗选择。

要点

  • 两组5年RFS与OS均无统计学显著差异
  • 两组复发模式无显著差异
  • SILC或可作为部分结肠癌患者可选术式

核心结论

  • 在5年OS和RFS方面,SILC组与MPC组之间无统计学显著差异,但该试验结果为探索性且检验效能不足。
  • SILC可能是有选择结肠癌患者可接受的治疗选择。

研究设计与样本

  • 随机对照试验的二次分析,评估长期结局(次要终点)。
  • 2012年3月1日至2015年3月31日共200例患者随机分配至MPC组(n=100)或SILC组(n=100)。
  • 纳入组织学证实位于盲肠、升结肠、乙状结肠或直肠乙状结肠的结肠癌、临床诊断为0-III期的患者,术前随机并接受完整结肠系膜切除术。
  • 全组中位随访61.0个月,采用意向性分析。

主要发现

  • 5年RFS:MPC组91.0%(95%CI 85.1%-96.9%),SILC组88.0%(95%CI 82.1%-93.9%),HR 1.37(95%CI 0.58-3.24),P=0.479。
  • 5年OS:MPC组95.0%(95%CI 91.1%-98.9%),SILC组93.0%(87.1%-98.9%),HR 1.39(95%CI 0.44-4.39),P=0.568。
  • 两组复发模式无显著差异。

临床怎么用

  • 对于有选择的结肠癌患者,SILC可作为MPC之外的备选术式,但需结合术者经验与患者具体情况个体化决策。

局限性

  • 作者指出5年OS和RFS结果为探索性且检验效能不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate the long-term outcomes that were the secondary endpoints of a RCT of multi-port laparoscopic colectomy (MPC) versus SILC in colon cancer surgery. SUMMARY OF BACKGROUND DATA: The actual long-term outcomes, such as the 5-year RFS, OS, and recurrence patterns after surgery, have not been evaluated by a RCT. METHODS: Patients with histologically proven colon carcinoma located in the cecum, ascending, sigmoid or rectosigmoid colon clinically diagnosed as stage 0-III were eligible for this study. Patients were preoperatively randomized and underwent complete mesocolic excision. The 5-year RFS, OS, and recurrence patterns were analyzed (UMIN-CTR 000007220). RESULTS: Between March 1, 2012, and March 31, 2015, a total of 200 patients were randomly assigned to either the MPC arm (n = 100) or SILC arm (n = 100). The median follow-up for all patients was 61.0 months. An intention-to-treat analysis showed that the 5-year RFS was 91.0% [95% confidence interval (CI) 85.1%-96.9%] in the MPC arm and 88.0% (95% CI 82.1%-93.9%) in the SILC arm (hazard ratio: 1.37; 95% CI 0.58-3.24; P = 0.479). The 5-year OS was 95.0% (95% CI 91.1%-98.9%) in the MPC arm and 93.0% (87.1%-98.9%) in the SILC arm (hazard ratio: 1.39; 95% CI 0.44-4.39; P = 0.568). There were no significant differences in the recurrence patterns between the 2 arms. CONCLUSIONS: Even though the results of the 5-year OS and RFS in this trial were exploratory and underpowered, there were no statistically significant differences between the SILC and MPC arms. SILC may be an acceptable treatment option for select patients with colon cancer.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Watanabe J, Ishibe A, Suwa H, et al. Long-term Outcomes of a Randomized Controlled Trial of Single-incision Versus Multi-port Laparoscopic Colectomy for Colon Cancer. Ann Surg. 2021. PMID: 33630448. doi:10.1097/SLA.0000000000004252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。